Skip to content
Search for:
COMPANY
PIPELINE
PATIENTS
PUBLICATIONS
INVESTORS & MEDIA
CONTACT
Company
cyteir
2023-02-06T09:55:46-05:00
Company
Cancer’s Vulnerability is Our Strength
MANAGEMENT
Markus Renschler, MD
President & Chief Executive Officer
Susan Doleman
VP, Clinical Operations
Jean-Marc Lapierre, PhD
SVP, Chemistry
Paul Secrist, PhD
Chief Scientific Officer
Judson Englert, MD, PhD
SVP, Clinical Research & Development
Krisztina Nemenyi, PhD, RAC
SVP, Regulatory Affairs and Quality
Adam Veness, Esq.
General Counsel
David Gaiero
Chief Financial Officer
Tom O'Shea, PhD
SVP, Clinical Pharmacology and Preclinical Development
BOARD OF DIRECTORS
Joseph S. Zakrzewski
Independent Investor & Chairman, Cyteir Therapeutics
Jeffrey Humphrey, MD
CEO, Stealth Biotechnology Company
Timothy Romberger
Founder Cyteir Therapeutics & TRC Advisory
Racquel Bracken
Venrock
Susan Molineaux, PhD
President and CEO of Calithera Biosciences
Stephen Sands
Vice Chairman Investment Banking and Chairman of Global Healthcare Group, Lazard
Jean George, MBA
Lightstone Ventures
Markus Renschler, MD
President & Chief Executive Officer
John Thero
Board of Directors at CinCor Pharma
Go to Top